MELD PRIORITIZATION FOR PATIENTS WITH CIRRHOSIS AND SMALL UNRESECTABLE HEPATOCELLULAR CARCINOMA HAS A MORE POSITIVE IMPACT IN WAITING TIME AND POST TRANSPLANT RECURRENCE FREE SURVIVAL THAN LIVING DONOR LIVER TRANSPLANTATION | Publicación